EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Berberine alleviates pyroptosis of retinal ganglion cells in diabetic retinopathy by regulating AKT1, JUN, and STAT3

Na Li, Ji-Lin Chen, Yi-Jian Sun iD, Jia-Fan Sun, Fatin Athirah Pauzi, Song-Lin Zhu, Amy Yi Hsan Saik, Alan Han-Kiat Ong

Ibrain · 2026-06 · 12 (2) · 222-237

DOI: 10.1002/ibra.70018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ibrain, online erschienen am 26.03.2026. Verfasst von Na Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: M. Kandiah Faculty of Medicine and Health Sciences Universiti Tunku Abdul Rahman Kajang Malaysia. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Berberine (BBR) exerts an effective protection for diabetic retinopathy (DR), but the underlying key molecular mechanism remains unknown; this study investigated the protective mechanism of BBR on DR by alleviating cell pyroptosis. A rat DR model was established and treated with BBR, and histological analyses, including hematoxylin and eosin staining, Nissl staining, and immunofluorescence, were executed to evaluate tissue changes. Core target genes were identified using the GeneCards database, Venn diagram analysis, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, protein‐protein interaction networks, and molecular docking. Validation of key genes was performed via reverse transcription‐quantitative polymerase chain reaction (RT‐qPCR), Western blot, and RNA interference. BBR improved retinal morphology, reduced edema, and restored the arrangement of retinal ganglion cells in DR rats. BBR significantly reduced the levels of pyroptosis markers such as IL‐1β and IL‐18, which were elevated in DR. Network pharmacology identified 10 hub genes, with six genes ( JUN , STAT3 , AKT1 , TP53 , IL‐1B , EGFR ) further analyzed. BBR reversed DR‐induced upregulation of JUN , STAT3 , and AKT1 at both the mRNA and protein levels, as confirmed by RT‐qPCR and Western blot. Silencing these genes enhanced cell viability and amplified BBR's protective effects. Altogether, BBR alleviates retinal inflammation and pyroptosis in diabetic retinal ganglion cells by targeting JUN , STAT3 , and AKT1 , providing insights into its therapeutic potential for DR.

Schlagwörter

Stichwörter der Autor:innen

berberinecell pyroptosisdiabetic retinopathynetwork pharmacology

Autor:innen und Institutionen

  • M. Kandiah Faculty of Medicine and Health Sciences Universiti Tunku Abdul Rahman Kajang Malaysia.
  • Institute of Neuroscience Kunming Medical University Kunming China.

ORCID-Profile: Yi-Jian Sun

Zitieren

APA

Li, N., Chen, J. L., Sun, Y. J., Sun, J. F., Pauzi, F. A., Zhu, S. L., Saik, A. Y. H., & Ong, A. H. (2026). Berberine alleviates pyroptosis of retinal ganglion cells in diabetic retinopathy by regulating AKT1, JUN, and STAT3. Ibrain, 12(2), 222-237. https://doi.org/10.1002/ibra.70018

Vancouver

Li N, Chen JL, Sun YJ, Sun JF, Pauzi FA, Zhu SL, et al. Berberine alleviates pyroptosis of retinal ganglion cells in diabetic retinopathy by regulating AKT1, JUN, and STAT3. Ibrain. 2026;12(2):222-237. doi:10.1002/ibra.70018

BibTeX
@article{Li2026,
  author = {Li, Na and Chen, Ji-Lin and Sun, Yi-Jian and Sun, Jia-Fan and Pauzi, Fatin Athirah and Zhu, Song-Lin and Saik, Amy Yi Hsan and Ong, Alan Han-Kiat},
  title = {Berberine alleviates pyroptosis of retinal ganglion cells in diabetic retinopathy by regulating AKT1, JUN, and STAT3},
  journal = {Ibrain},
  year = {2026},
  volume = {12},
  number = {2},
  pages = {222--237},
  doi = {10.1002/ibra.70018}
}
Kostenlos starten →